Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Principal Contrarian Value Index ETF (NY:PVAL)

53.00 +0.43 (+0.82%)
Official Closing Price Updated: 8:00 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,682,737
Open 52.66
Bid (Size) 52.05 (1,000)
Ask (Size) 54.75 (4,700)
Prev. Close 52.57
Today's Range 52.52 - 53.16
52wk Range 39.71 - 53.16
Shares Outstanding 897,290
Dividend Yield 1.06%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an upside of more than 13% from NVO stock’s closing price on Monday. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing. 
Via Stocktwits
Topics Intellectual Property Lawsuit

Performance

YTD
+15.2%
+15.2%
1 Month
+3.7%
+3.7%
3 Month
+9.1%
+9.1%
6 Month
+12.3%
+12.3%
1 Year
+29.0%
+29.0%

More News

Read More
News headline image
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China ↗
Via Stocktwits
News headline image
Why Is NVO Stock Falling Pre-Market Today? ↗
Via Stocktwits
Topics Government
News headline image
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly ↗
Via Stocktwits
Topics Intellectual Property
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
Via Stocktwits
Topics Lawsuit
News headline image
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Sanofi, VNVC Launch Vaccine Manufacturing Facility In Vietnam, Says Report: Retail’s Positive ↗
Via Stocktwits
News headline image
Putnam Investments Launches Firm’s First Active ETFs
From Putnam Investments
Via Business Wire

Frequently Asked Questions

Is Principal Contrarian Value Index ETF publicly traded?
Yes, Principal Contrarian Value Index ETF is publicly traded.
What exchange does Principal Contrarian Value Index ETF trade on?
Principal Contrarian Value Index ETF trades on the New York Stock Exchange
What is the ticker symbol for Principal Contrarian Value Index ETF?
The ticker symbol for Principal Contrarian Value Index ETF is PVAL on the New York Stock Exchange
What is the current price of Principal Contrarian Value Index ETF?
The current price of Principal Contrarian Value Index ETF is 53.00
When was Principal Contrarian Value Index ETF last traded?
The last trade of Principal Contrarian Value Index ETF was at 07/28/26 08:00 PM ET
What is the market capitalization of Principal Contrarian Value Index ETF?
The market capitalization of Principal Contrarian Value Index ETF is 47.56M
How many shares of Principal Contrarian Value Index ETF are outstanding?
Principal Contrarian Value Index ETF has 48M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.